雜志介紹

Clinical Drug Investigation雜志介紹

《Clinical Drug Investigation》是一本以English為主的未開放獲取國際優秀期刊，中文名稱臨床藥物調查，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.9，最新CiteScore 指數為5.9。

本刊近期中國學者發表的論文主要有：

• Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment

  Author: Liu, Xinyu; Shi, Jian; Wang, Deyang; Su, Ying; Xing, Zhen; Sun, Fei; Chen, Fei

• Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis

  Author: Gao, Mengxia; Zhu, Lingqun; Chang, Jingling; Cao, Tianyu; Song, Lianying; Wen, Chunli; Chen, Yi; Zhuo, Yudi; Chen, Fei

• Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women

  Author: Shao, Feng; Jiang, Yi; Ding, Sijia; Larsson, Per; Pinton, Philippe; Jonker, Daniel Martijn

• A Risk-Scoring Model for Severe Checkpoint Inhibitor-Related Pneumonitis: A Case-Control Study

  Author: Deng, Haiyi; Deng, Jiating; Lin, Xinqing; Guan, Wenhui; Lin, Ziying; Qiu, Yanli; Yang, Yilin; Wu, Jianhui; Qiu, Guihuan; Sun, Ni; Zhou, Maolin; Deng, Jiaxi; Xie, Xiaohong; Xie, Zhanhong; Liu, Ming; Qin, Yinyin; Zhou, Yanbin; Zhou, Chengzhi

英文介紹

Clinical Drug Investigation雜志英文介紹

Clinical Drug Investigation provides rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. The Journal includes:

-Clinical trials, outcomes research, clinical pharmacoeconomic studies and pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs.

-Clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice.

-Pharmacodynamic and pharmacokinetic studies in healthy volunteers in which significant implications for clinical prescribing are discussed.

-Studies focusing on the application of drug delivery technology in healthcare.

-Short communications and case study reports that meet the above criteria will also be considered.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Clinical Drug Investigation may be accompanied by plain language summaries to assist readers who have some knowledge, but non in-depth expertise in, the area to understand important medical advances.